TokenPost topic

Edwards Lifesciences

1 TokenPost story is tagged Edwards Lifesciences. The newest appear first.

Latest Edwards Lifesciences stories

• Edwards Says PASCAL Outperformed Medical Therapy on Tricuspid Trial Endpoint

  At one year, 80% of PASCAL-treated patients had moderate or lower tricuspid regurgitation, compared with 30% of control patients.

  Nov 2, 2026, 6:35 PM EST · Business